Treatment for nonresectable hepatocellular carcinoma (HCC) is palliative. The relatively
greater arteriolar density of hepatic tumors compared with normal liver suggests that …

Purpose To evaluate safety and efficacy of radiation segmentectomy (RS) with 90 Y glass
microspheres in patients with limited metastatic liver disease not amenable to resection or …

Background Liver transplantation (LT) is a well-established procedure for hepatocellular
carcinoma (HCC) within the Milan criteria. Yttrium-90 microspheres radioembolization (Y90 …

Transarterial chemoembolization (TACE) is one of the standard locoregional treatments for
intermediate stage hepatocellular carcinoma (HCC). Transarterial radioembolization (TARE) …

PURPOSE: Yttrium-90 (90Y) radioembolization has emerged as a promising and safe
therapeutic modality for patients with hepatocellular carcinoma (HCC) or metastatic liver …

The purpose of this study was to compare the difference in prescribed radiation activity
between glass and resin yttrium‐90 (90 Y) microspheres for radioembolization of …

Simple Summary Transarterial radioembolization (TARE) of the liver with Yttrium-90 (Y-90)
microspheres is a prominent approach used to treat hepatocellular carcinoma (HCC), the …

PURPOSE: Radioembolization (RE) using 90Y-microspheres is an effective and safe
treatment for patients with unresectable liver malignancies. Radiation-induced liver disease …

Purpose: To investigate the antitumor effect of resin microspheres loaded with 90-yttrium
against hepatocellular carcinoma and their safety in the setting of liver cirrhosis. Patients …

Purpose We report on our experience in terms of eligibility, safety, response and survival for
treatment of hepatocellular carcinoma (HCC) with 90 Y microspheres. Secondly, we …